This prospective birth cohort study showed for the first time that the impact of important intestinal microbiota-shaping risk factors (the delivery mode and prenatal antibiotic exposure) on the early development of AD can be modified by the genetic background (functional IL-13 and CD14 gene variants) in a additive fashion. The gene discussed is IL13; the disease is Alzheimer disease.